分子薬理学的の

WordNet

relating to simple or elementary organization; "proceed by more and more detailed analysis to the molecular facts of perception"--G.A. Miller
relating to or produced by or consisting of molecules; "molecular structure"; "molecular oxygen"; "molecular weight is the sum of all the atoms in a molecule"
of or relating to pharmacology (同)pharmacologic

PrepTutorEJDIC

分子の,分子による

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. びまん性神経膠腫の分子学的発症機序molecular pathogenesis of diffuse gliomas [show details]
…murine models of diffuse high-grade glioma . Some of these molecular changes may represent potential targets for future gene or molecular pharmacologic therapies. However, single-agent therapeutic approaches …
2. 急性発症した入院内科患者における静脈血栓塞栓症の予防prevention of venous thromboembolic disease in acutely ill hospitalized medical adults [show details]
… increased risk of bleeding, we recommend the use of pharmacologic thromboprophylaxis rather than mechanical methods or no prophylaxis. Low molecular weight heparin is generally the preferred anticoagulant …
3. 整形外科手術以外の手術を受ける患者の静脈血栓性疾患の予防prevention of venous thromboembolic disease in adult nonorthopedic surgical patients [show details]
…suggest pharmacologic prophylaxis, preferably with low molecular weight (LMW) heparin, rather than no thromboprophylaxis . For patients at high risk of VTE, we recommend, at minimum, pharmacologic prophylaxis …
4. 整形外科手術を受ける成人患者の静脈血栓塞栓症の予防prevention of venous thromboembolism in adult orthopedic surgical patients [show details]
… Timing also depends upon the methods chosen: Low molecular weight and unfractionated heparin – Most experts agree that the administration of pharmacologic prophylaxis with LMW heparin should not be administered …
5. 先天性掌蹠角化症hereditary palmoplantar keratodermas [show details]
…or X-linked pattern. Mitochondrial inheritance has also been reported. Genetic defect/disrupted molecular pathway . Mutations in genes encoding structural proteins supporting the granular layer of the … Pharmacologic therapies that can be used for the treatment of PPK include topical keratolytics,…

English Journal

Fabrication of hesperidin nanoparticles loaded by poly lactic co-Glycolic acid for improved therapeutic efficiency and cytotoxicity.

Ali SH, Sulaiman GM, Al-Halbosiy MMF, Jabir MS, Hameed AH.
Artificial cells, nanomedicine, and biotechnology. 2019 Dec;47(1)378-394.
Hesperidin, as a flavonone, is recognized as promising anti-inflammatory, antioxidant, and anticancer agent. Its poor bioavailability is crucial bottleneck for therapeutic efficacy. To enhance the stability and bioactive potentials, hesperidin -PLGA-Poloxamer 407 was successfully prepared to minimiz
PMID 30691314

Green synthesis of zinc oxide nanoparticles using different plant extracts and their antibacterial activity against Xanthomonas oryzae pv. oryzae.

Ogunyemi SO, Abdallah Y, Zhang M, Fouad H, Hong X, Ibrahim E, Masum MMI, Hossain A, Mo J, Li B.
Artificial cells, nanomedicine, and biotechnology. 2019 Dec;47(1)341-352.
The synthesis of metal oxide nanoparticles with the use of plant extract is a promising alternative to the conventional chemical method. This work aimed to synthesize zinc oxide nanoparticles (ZnONPs) using plant extract of chamomile flower (Matricaria chamomilla L.), olive leave (Olea europaea) and
PMID 30691311

Stimuli-responsive polyvinylpyrrolidone-NIPPAm-lysine graphene oxide nano-hybrid as an anticancer drug delivery on MCF7 cell line.

Ashjaran M, Babazadeh M, Akbarzadeh A, Davaran S, Salehi R.
Artificial cells, nanomedicine, and biotechnology. 2019 Dec;47(1)443-454.
Despite the advances in the development of chemotherapeutic agents, resistance to chemotherapy and adverse side effects are still big challenges against successful cancer treatment. To overcome these problems, one strategy is the application of nanomaterials and drug delivery systems to efficiently
PMID 30688104

Japanese Journal

Evaluation of the Inhibitory Effects of Rokumigan and Hachimijiogan on Cataract Formation in a Rat Model of Streptozotocin-induced Type 1 Diabetes —Effect of Hachimijiogan on Diabetic Cataracts—